CAS RN: 2246364-68-9
2-Bromo-4,5,6,8-tetrahydropyrazolo[1,5-d][1,4]diazepin-7-one
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250911
250mg / 1g
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2246364-68-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
2246364-68-9 / 2-bromo-4,5,6,8-tetrahydropyrazolo[1,5-d][1,4]diazepin-7-one
Standard CAS: 2246364-68-9
Multi CAS: No
Basic Information
copy
CAS
2246364-68-9 copy
Multi CAS
No copy
Molecular Formula
C7H8BrN3O copy
Molecular Weight
230.060000 copy
Exact Mass
228.985070 copy
SMILES
C1CNC(=O)CN2C1=CC(=N2)Br copy
InChI
InChI=1S/C7H8BrN3O/c8-6-3-5-1-2-9-7(12)4-11(5)10-6/h3H,1-2,4H2,(H,9,12) copy
InChIKey
JGPKEAXWRNIQLO-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
12 copy
Aromatic heavy atom count
5 copy
Fraction Csp3
0.43 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
46.64 copy
TPSA
46.92 copy
LogP / Solubility
WLOGP
0.32 copy
MLOGP
0.28 copy
XLogP3
0.8 copy
Consensus LogP
0.47 copy
Log S (ESOL)
-1.78 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.68 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.42 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.9 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy